CIPLA
|
The Current P/B Ratio of CIPLA is 3.46.
| Share Price | ₹1,329.6 | Feb 12,2026 |
| Market Cap | ₹107,401.0 Cr | |
| Book Value | ₹31,079.3 Cr | Mar2025 - Consolidated Results |
| Price/Book | 3.46x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹107,401.0 Cr] as on Feb 12,2026
(/) Book Value [ ₹31,079.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 3.46x ]
Thus, for CIPLA , the investors are currently willing to pay '3.46 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.79x.
- CIPLA 's operated at median p/b ratio of 3.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2024 at 4.53x.
- CIPLA 's p/b ratio hit its five-year low in Mar2023 of 3.11x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| CIPLA | 31,079.30 | 3.46 | 107,401.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.70 | 411,402.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 10.97 | 164,277.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 18.20 | 138,140.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.18 | 106,378.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.01 | 85,818.0 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.87 | 92,654.0 |
| LUPIN LTD | 17,119.50 | 5.90 | 100,999.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.06 | 67,230.7 |
| ABBOTT INDIA LTD | 4,204.27 | 13.49 | 56,703.6 |
| ALKEM LABORATORIES LTD | 11,948.70 | 5.86 | 70,044.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.06x |
| Max industry PB | 18.20x |
| Median industry PB | 5.86x |
| Average industry PB | 7.15x |
You may also like the below Video Courses